| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2011 | EP2268146A1 Indoline anti-cancer agents |
| 01/05/2011 | EP2268143A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 01/05/2011 | EP2268141A1 Compounds and method for reducing uric acid |
| 01/05/2011 | EP2268140A2 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 01/05/2011 | EP2178504B1 Preservative-free prostaglandin-based ophthalmic solution |
| 01/05/2011 | EP2146974B1 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
| 01/05/2011 | EP2121696B1 Compounds for the treatment of hepatitis c |
| 01/05/2011 | EP2094706B1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 01/05/2011 | EP2083832B1 Novel 1,4-benzothiepin-1,1-dioxide derivatives with improved properties, method for producing the same, drugs containing said compounds and use thereof |
| 01/05/2011 | EP2076508B1 Biaryl ether urea compounds |
| 01/05/2011 | EP2029139B1 Use of a p38 kinase inhibitor for treating psychiatric disorders |
| 01/05/2011 | EP2001483B1 Use of cholest-4-ene-3-one derivatives to obtain a cytoprotective medicine |
| 01/05/2011 | EP1952293B1 Methods for the identification of microrna and their applications in research and human health |
| 01/05/2011 | EP1948606B1 3, 5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 01/05/2011 | EP1948176B1 Diaryl ureas for treating pulmonary hypertension |
| 01/05/2011 | EP1937281B1 Modulation of trpv expression levels |
| 01/05/2011 | EP1931782B1 Methods for use in modulating mir-122a |
| 01/05/2011 | EP1912999B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/05/2011 | EP1908467B1 Agent for treating herpesvirus-derived pain |
| 01/05/2011 | EP1905442B1 Utilization of anti-neuropathic pain effect of d-allose and d-psicose |
| 01/05/2011 | EP1881977B1 Histone deacetylase inhibitors |
| 01/05/2011 | EP1820794B1 Method of obtaining cyclic amino acids |
| 01/05/2011 | EP1812387B1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 01/05/2011 | EP1797088B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/05/2011 | EP1771180B2 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 01/05/2011 | EP1765356B2 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 01/05/2011 | EP1750862B1 Pharmaceutical composition containing irbesartan |
| 01/05/2011 | EP1747023B1 Methods and compositions for reducing hcv viral genome amounts in a target cell |
| 01/05/2011 | EP1725233B1 Pharmaceutical composition comprising sns-595 and uses thereof |
| 01/05/2011 | EP1720882B1 Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors |
| 01/05/2011 | EP1706489B9 Oligomeric compounds for the modulation of bcl-2 |
| 01/05/2011 | EP1680110B1 Once daily dosage forms of trospium |
| 01/05/2011 | EP1677795B1 Muscarinic acetycholine receptor antagonists |
| 01/05/2011 | EP1661890B1 Ppar-activating compound and pharmaceutical composition containing same |
| 01/05/2011 | EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
| 01/05/2011 | EP1603941B1 Inhibitors of extracellular hsp90 |
| 01/05/2011 | EP1567138B1 Use of a diamide derivative for inhibiting chronic transplant rejection |
| 01/05/2011 | EP1558256B1 Pyrroloquinoline quinone and a beta blocker for the treatment of ischemia or reperfusion injury |
| 01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1488796B1 Chromanol glucosides for ameliorating cancer chemotherapy |
| 01/05/2011 | EP1482964B1 Use of egfr transactivation inhibitors in human cancer |
| 01/05/2011 | EP1465637B1 25-hydroxy vitamin d3 compositions |
| 01/05/2011 | EP1446381B1 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP1433480B1 Medicine containing pyrimidine derivative |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1365778B1 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 01/05/2011 | EP1307218B1 Treatment of obesity |
| 01/05/2011 | EP1147214B1 A novel method for designing protein kinase inhibitors |
| 01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
| 01/05/2011 | EP1085862B1 Treatment of an autoimmune disease |
| 01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
| 01/05/2011 | CN201692350U Bra technical structure |
| 01/05/2011 | CN201692349U Amlodipine polypharmacy valsartan capsule tablet |
| 01/05/2011 | CN201691015U Lycopene microcapsule |
| 01/05/2011 | CN1988934B Tetrahydropyridothiophenes |
| 01/05/2011 | CN1970536B Preparation process of probucol monobutane diacid ester |
| 01/05/2011 | CN1951952B Triterpene compound for preparing drug for treating cranial glia tumour |
| 01/05/2011 | CN1927193B Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients |
| 01/05/2011 | CN1905866B Tulobuterol adhesive patch |
| 01/05/2011 | CN1875944B A carbowax modified stealthy liposome nanosphere of hydroxycamtothecine and preparation method thereof |
| 01/05/2011 | CN1788748B Detection method of injection formulation containing raw material herb red sage root or red sage |
| 01/05/2011 | CN1703229B Compositions and uses for treatment of prostate and other cancers |
| 01/05/2011 | CN101939446A MicroRNA signatures in human ovarian cancer |
| 01/05/2011 | CN101939336A AXL antibodies |
| 01/05/2011 | CN101939327A New macrolides and their use |
| 01/05/2011 | CN101939326A Method for producing cycloplatinized platinum complexes, platinum complexes produced by said method, and the use thereof |
| 01/05/2011 | CN101939324A Pyrrolopyrazine kinase inhibitors |
| 01/05/2011 | CN101939323A Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 01/05/2011 | CN101939322A Sildenafil n-oxide as prodrug |
| 01/05/2011 | CN101939321A Production method and production device for composition having high content of theobromine |
| 01/05/2011 | CN101939320A Polymorphic form |
| 01/05/2011 | CN101939319A Bis-thiazole derivatives, process for their preparation and their use as medicaments |
| 01/05/2011 | CN101939318A Substituted piperidines as renin inhibitors |
| 01/05/2011 | CN101939317A Substituted aryloxazoles and the use thereof |
| 01/05/2011 | CN101939316A Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
| 01/05/2011 | CN101939315A Gamma secretase modulators |
| 01/05/2011 | CN101939314A Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939312A Gamma secretase modulators |
| 01/05/2011 | CN101939311A Heterocyclic compounds with affinity to muscarinic receptors |
| 01/05/2011 | CN101939306A Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 01/05/2011 | CN101939303A Novel crystalline forms |
| 01/05/2011 | CN101939300A 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| 01/05/2011 | CN101939297A Benzylpiperizine compound |
| 01/05/2011 | CN101939293A N-oxides of venlafaxine and O-desmethylvenlafaxine as prodrugs |
| 01/05/2011 | CN101939291A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 01/05/2011 | CN101939289A Novel process for the preparation of vorinostat |
| 01/05/2011 | CN101939288A Difluorobiphenylamide derivatives for the treatment of ocular hypertension |
| 01/05/2011 | CN101939287A Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl -propyl)-phenol |
| 01/05/2011 | CN101939055A 2-aminoquinolines |
| 01/05/2011 | CN101939054A Organic compounds |
| 01/05/2011 | CN101939053A Soluble guanylate cyclase activators |
| 01/05/2011 | CN101939030A Use of alginate oligomers in combating biofilms |
| 01/05/2011 | CN101939026A Antibacterial combination therapy |
| 01/05/2011 | CN101939024A Compositions for the treatment of inflammation of the gastrointestinal tract |
| 01/05/2011 | CN101939017A Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
| 01/05/2011 | CN101939013A Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain due to vascular smooth muscle spasm |
| 01/05/2011 | CN101939012A Macrolides for treating diseases mediated through PDE inhibition |
| 01/05/2011 | CN101939011A Compositions and methods for influencing recovery from strenuous physical activity |